skip to Main Content

AI Enabled Cerebral Infarction Diagnosis Assistance – HACARUS & Ohara Pharmaceutical

AI Enabled Cerebral Infarction Diagnosis Assistance - HACARUS & Ohara Pharmaceutical  Highly specialized MRI image interpretation technology is required to diagnose cerebral infarction, and accurate treatment type selection is required to select a treatment method. In particular, the treatment of acute cerebral infarction is time-consuming and requires prompt diagnosis and treatment. There are many hospitals that do not have a cerebral infarction specialist even though they have MRI imaging equipment. To tackle this issue, HACARUS and OHARA Pharmaceutical Co.,Ltd. are…

Joint research for Liver Cancer diagnosis support tool

Joint research for Liver Cancer diagnosis support tool A current shortage of specialists possessing the required knowledge to interpret the scans means that the healthcare system is increasingly unable to meet a growing demand for diagnosis. Therefore HACARUS and Kobe University will conduct joint research aiming to: (1) Detect risk areas in MRI images using AI trained by using supervised learning. (2) Perform HCC disease type classification in risk areas. (3) Create an accurate AI type classification and diagnosis support…

AI support system for prevention and early diagnosis of cervical cancer

AI support system for prevention and early diagnosis of cervical cancer HACARUS and Kyoto University aim to digitize specialist oncologist’s know-how and during the joint R&D project the two parties will: Build a highly accurate AI model for early cancer detection using colposcopy video data, enable AI fueled diagnosis support in line with the diagnosis and treatment standards of Japan and construct a tool that can identify lesions with high accuracy and assist diagnosis of tissue sampling in facilities where…

AI based anomaly detection in ECG signals – Solution development with ITK Engineering

AI based anomaly detection in ECG signals - Solution development with ITK Engineering The German technology company ITK Engineering – a subsidiary of Bosch – and Hacarus have jointly developed a proof of concept for a personalized patient monitoring system, serving to evaluate ECG signals. It not only evaluates anomalies in a single patient heart’s ECG in near real-time, but also provides at-a-glance comparisons with the expected normal ECG curve.

Partnership with DS Pharma Animal Health

Partnership with DS Pharma Animal Health DS Pharma Animal Health and Hacarus are developing a non-intrusive ECG measurement and analytics tool for animals, based on a connected sheet that has the ability to capture vital heart data from standing animals paws. The sheet is connected to an edge base station, which includes the AI software by Hacarus, which then communicates with a cloud platform (あにさぽ®) for veterinarians provided by DS Pharma Animal Health.